Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Inflammatory Bowel Diseases
|
June 16, 2025
Dualistic Implications of Angiotensin-Converting Enzyme 2 (ACE2) Expression in Inflammatory Bowel Disease
Arno R Bourgonje
Gastroenterology
|
October 24, 2022
Microbial Riboflavin Biosynthesis Associates With Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients With Inflammatory Bowel Disease?
Arno R Bourgonje
Journal of Crohn'S & Colitis
|
August 13, 2022
Evaluating Discriminative Accuracy of Biomarkers in Relation to Binary Study Outcomes: First Validate, Then Celebrate?
Arno R Bourgonje
Gastroenterology
|
February 25, 2026
Rethinking Infliximab Dosing in Acute Severe Ulcerative Colitis with Model-Informed Precision Dosing
Arno R Bourgonje, Paola Mian
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 9, 2025
Advancing Proactive Therapeutic Drug Monitoring with Model-Informed Precision Dosing in Pediatric Crohn's Disease
Arno R Bourgonje, Paola Mian
Digestive Diseases and Sciences
|
March 6, 2025
Understanding the Impact of Prior Anti-TNF Exposure on Colectomy Risk in Acute Severe Ulcerative Colitis
Arno R Bourgonje, Maia Kayal
The American Journal of Gastroenterology
|
November 30, 2023
Identifying Phenotypic Determinants of Infliximab Target Concentrations in Inflammatory Bowel Disease: Toward Personalized Evidence-Based Dosing Regimens
Arno R Bourgonje, Paola Mian
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 15, 2023
The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?
Arno R Bourgonje, Antonius T Otten
The Lancet. Gastroenterology & Hepatology
|
December 8, 2022
Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
Antonius T Otten, Arno R Bourgonje, Marijn C Visschedijk
Inflammatory Bowel Diseases
|
May 17, 2026
Translating multiomics prediction into clinical care in Crohn's disease: Moving beyond proof of concept
Foekjen E Veenstra, Maximilian G Griesbaum, Arno R Bourgonje
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Inflammatory Bowel Diseases
|
June 16, 2025
Dualistic Implications of Angiotensin-Converting Enzyme 2 (ACE2) Expression in Inflammatory Bowel Disease
Arno R Bourgonje
Gastroenterology
|
October 24, 2022
Microbial Riboflavin Biosynthesis Associates With Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients With Inflammatory Bowel Disease?
Arno R Bourgonje
Journal of Crohn'S & Colitis
|
August 13, 2022
Evaluating Discriminative Accuracy of Biomarkers in Relation to Binary Study Outcomes: First Validate, Then Celebrate?
Arno R Bourgonje
Gastroenterology
|
February 25, 2026
Rethinking Infliximab Dosing in Acute Severe Ulcerative Colitis with Model-Informed Precision Dosing
Arno R Bourgonje, Paola Mian
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 9, 2025
Advancing Proactive Therapeutic Drug Monitoring with Model-Informed Precision Dosing in Pediatric Crohn's Disease
Arno R Bourgonje, Paola Mian
Digestive Diseases and Sciences
|
March 6, 2025
Understanding the Impact of Prior Anti-TNF Exposure on Colectomy Risk in Acute Severe Ulcerative Colitis
Arno R Bourgonje, Maia Kayal
The American Journal of Gastroenterology
|
November 30, 2023
Identifying Phenotypic Determinants of Infliximab Target Concentrations in Inflammatory Bowel Disease: Toward Personalized Evidence-Based Dosing Regimens
Arno R Bourgonje, Paola Mian
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 15, 2023
The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?
Arno R Bourgonje, Antonius T Otten
The Lancet. Gastroenterology & Hepatology
|
December 8, 2022
Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
Antonius T Otten, Arno R Bourgonje, Marijn C Visschedijk
Inflammatory Bowel Diseases
|
May 17, 2026
Translating multiomics prediction into clinical care in Crohn's disease: Moving beyond proof of concept
Foekjen E Veenstra, Maximilian G Griesbaum, Arno R Bourgonje
Page
of 14